NICE guidelines on active management of patients with COVID-19
The National Institute for Health and Care Excellence (NICE) has published its first three rapid guidelines on the active management of patients with COVID-19...
eyeforpharma Barcelona goes VIRTUAL
Spotlight: Advertorial from Pf Partners
Hi Covid-19 has undoubtedly created one of the most challenging environments of the modern era. Together, we must step up to...
CMA launches COVID-19 taskforce to monitor market practices
The CMA is launching a COVID-19 taskforce to tackle negative impacts within its remit of the coronavirus pandemic. The outbreak of Covid-19 is an unprecedented...
LifeArc launches £10m COVID-19 clinical research fund
LifeArc, a UK-based medical research charity, has created a £10m COVID-19 clinical research fund to support research to accelerate the development and testing of...
Synairgen to start trial of SNG001 in COVID-19
Respiratory drug discovery and development company Synairgen has received expedited approvals from the Medicines and Healthcare products Regulatory Agency (MHRA) and Health Research Authority...
Study of siltuximab for treating COVID-19 serious respiratory complications initiated
A study of siltuximab for treating COVID-19 serious respiratory complications has been initiated. EUSA Pharma has announced the initiation of the Papa Giovanni XXIII Hospital...
First coronavirus vaccine clinical trial starts
The first coronavirus vaccine clinical trial has started at Kaiser Permanente Washington Health Research Institute (KPWHRI) in Seattle. The Phase 1 clinical trial is...
FDA emergency authorisation for Roche’s COVID-19 test
Roche has announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for its COVID-19 test, the cobas®...
Elsevier gives full access to its coronavirus information centre content
Elsevier is giving full access to its content on its coronavirus information centre for PubMed Central and other public health databases, such as the...
Free scientific advice for coronavirus medicine or vaccine developers
The European Medicines Agency is offering free scientific advice to coronavirus medicine or vaccine developers. EMA is providing full fee waivers for scientific advice applications from...
Latest articles
Sanofi’s avalglucosidase alfa receives Promising Innovative Medicine designation
Sanofi has announced that the UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) has issued a Promising Innovative Medicine (PIM) designation for avalglucosidase alfa...
Current trends in compliance
The COVID-19 pandemic has taught us many lessons, but are we missing an age-old one that we all need to learn and act upon?...
LEO Pharma appoints new People Director
Specialist dermatology company, LEO Pharma UK/Ireland, has appointed a new People Director for its North Europe ‘cluster’ countries. Julie Watret joins from Network Rail,...
Popular articles
New Normal, New Thinking: Life Post COVID-19
New thinking will be required to adapt to the new normal life post COVID-19. I hate to start this article on a negative note, but...
LEO Pharma appoints new People Director
Specialist dermatology company, LEO Pharma UK/Ireland, has appointed a new People Director for its North Europe ‘cluster’ countries. Julie Watret joins from Network Rail,...
JYSELECA®▼(filgotinib) receives authorisation as treatment for rheumatoid arthritis
It has been announced that JYSELECA®▼(filgotinib), an oral JAK inhibitor, has received marketing authorisation from the European Commission (EC) for the treatment of moderate...
Kate Bingham appointed Chair of UK Vaccine Taskforce
Kate Bingham has been appointed Chair of the UK’s Vaccine Taskforce – the group set up by the Government’s Chief Scientific Adviser, Deputy Chief...
It’s all in the mind(set): digital transformation in pharma
The importance of mindset and company culture to enable digital transformation in pharma. Top 5 Takeaways Start with defining and understanding the traditional roadblocks of...